Back to Top Skip to main content

Pandemic Diseases

Medical Countermeasures (MCM) assumes a proactive, preventive approach to protect service members and their families who may be stationed or deployed in areas at elevated risk to both naturally occurring and manufactured emerging infectious diseases. MCM develops clinical use guidelines for vaccines, diagnostics and antiviral policies that protect the military, civilian personnel and beneficiaries to preserve U.S. combat capabilities and readiness. They also contribute to U.S. government-wide efforts to save lives reduce human suffering and slow the spread of infection. 

This includes managing and updating vaccine use policies to counter infectious disease threats such as smallpox and anthrax, and ensuring the safest and most effective preventive measures are in place to address adenovirus-associated illness and unique regional illnesses such as malaria, Japanese Encephalitis and leishmaniasis.

Photo of U.S. Air Force Staff Sgt. Jon Rigenoldus, 509th Medical Support Squadron medical lab technician, examines samples at Whiteman Air Force Base, Mo., March 18, 2015.

MCM interacts with DoD’s Chemical and Biological Defense Program, to assist in the following:  

  • Development of medical countermeasure requirements 
  • Acquisition processes
  • New product evaluations 
  • Determination of appropriate stockpiling 

MCM ensures that safe, effective medicines are in place and available when needed.

You also may be interested in...

Military medicine promotes global health security with partner nations in West Africa

Article
3/9/2017
Dr. David J. Smith, performing the duties of the assistant secretary of Defense for Health Affairs, right, and Dr. Chris Daniel, senior advisor for global health engagement, (second from right), discuss laboratory capabilities with Nigerian medical officials. (Courtesy photo)

Working with partner nations to develop medical capabilities and experience is a critical part of our military medical mission

Recommended Content:

Global Health Engagement | Global Health Security Agenda | Pandemic Diseases

Army researchers, Sanofi Pasteur to co-develop Zika virus vaccine

Article
7/13/2016
A digitally-colorized transmission electron micrograph of Zika virus, which is a member of the family Flaviviridae. Virus particles, here colored blue, are 40 nanometers in diameter with an outer envelope and an inner dense core.

A recently signed cooperative research and development agreement will allow the transfer of the Zika purified inactivated virus, or ZPIV, technology to Sanofi to explore advanced and larger-scale manufacturing and production

Recommended Content:

Research and Innovation | Pandemic Diseases | Immunization Healthcare | Mosquito-Borne Illnesses | Zika Virus | Public Health

DoD adds funding to enhance Zika surveillance by military labs

Article
5/18/2016
This photograph depicts a female Aedes aegypti mosquito, the species of mosquito primarily responsible for the spread of the Zika virus disease to people.

The Defense Department is providing $1.76 million in extra funding to military laboratories to expand Zika virus surveillance worldwide

Recommended Content:

Pandemic Diseases | Public Health | Medical Research and Development | Zika Virus | Armed Forces Health Surveillance Branch | Global Emerging Infections Surveillance and Response System | Mosquito-Borne Illnesses

Army scientists begin first MERS vaccine clinical trial

Article
2/22/2016
This image shows Middle East respiratory syndrome coronavirus particle envelope proteins immunolabeled with rabbit HCoV-EMC/2012 primary antibody and goat anti-rabbit 10-nanometer gold particles. (National Institute of Allergy and Infectious Disease photo)

A MERS vaccine would be an important medical countermeasure for U.S. troops in the Middle East and wherever the virus might arise

Recommended Content:

Immunization Healthcare | Pandemic Diseases | Middle East Respiratory Syndrome Coronavirus | Immunization Healthcare | Immunizations

Rise of the bugs, and the DoD Biosurveillance Enterprise

Article
2/2/2016
String-like Ebola virus particles shed from an infected cell are seen here in this electron micrograph. (National Institute of Allergy and Infectious Diseases photo)

Global Emerging Infections Surveillance, part of the Defense Health Agency’s Armed Forces Health Surveillance Branch, keeps a watch for emerging infectious diseases

Recommended Content:

Armed Forces Health Surveillance Branch | Global Emerging Infections Surveillance and Response System | Pandemic Diseases | Ebola | Public Health

U.S. Government Global Health Security Agenda Partners

Photo
1/29/2016
U.S. Government Global Health Security Agenda Partners

Recommended Content:

Pandemic Diseases | Global Health Engagement

MHS supports Global Health Security Agenda through its Force Health Protection Mission

Article
1/29/2016
U.S. Government Global Health Security Agenda Partners

For nearly two decades, the Military Health System has supported global public health surveillance to protect its forces and allies

Recommended Content:

Global Health Engagement | Pandemic Diseases | Global Health Security Agenda

Military Health System helping in the fight against HIV on World AIDS Day

Article
12/1/2015
Participants and instructors in the Department of Defense HIV/AIDS Prevention Program’s inaugural Regional Military International HIV Training Program in Lilongwe, Malawi.

The MHS introduced a new clinical training program with partner nations for HIV prevention and treatment, as part of its mission to conduct global health engagement and to contribute to the global fight against HIV/AIDS.

Recommended Content:

Global Health Engagement | Pandemic Diseases | Building Partner Capacity and Interoperability

Chairman of the Joint Chiefs of Staff Instruction: Post-Deployment Policy for 21-day Controlled Monitoring

Policy

This instruction provides policy and guidance for the Services in the conduct of 21-day controlled monitoring of Service members and volunteering DoD civilian employees returning from the Ebola virus disease (EVD) outbreak area in West Africa.

Ebola Fact Sheet for Families of Deploying Personnel

Fact Sheet
11/4/2014

The President and the Secretary of Defense have called upon the men and women of the US armed forces and other government personnel to provide critical support as part of the international response to the Ebola outbreaks in West Africa. This Fact Sheet highlights the actions that are in place prior to, during, and after deployment in order to protect ...

Recommended Content:

Ebola | Operation United Assistance | Information for Military Families | Pandemic Diseases

Pre-Deployment, Deployment, and Post-Deployment Training, Screening, and Monitoring Guidance for Department of Defense Personnel Deployed to Ebola Outbreak Areas

Policy

Department of Defense (DoD) personnel (Service members and civilian employees)deployed to Centers for Disease Control and Prevention defined Ebola outbreak areas will complete pre and post-deployment screening and training requirements outlined in this memorandum and supplemented by United States Africa Command (USAFRICOM) guidance.

Detecting and Reporting DoD Cases of Ebola Virus Disease Infection

Policy

Guidance as of 17 OCT 2014 from the Department of Defese (AFHSC)for Detecting and Reporting DoD Cases of Ebola Virus Disease Infection

CDC Ebola Fact Sheet

Fact Sheet
10/10/2014

A fact sheet from the Centers for Disease Control describing Ebola, transimission, signs and symptoms, risk of exposure, diagnosis, treatment and prevention.

Recommended Content:

Ebola | Conditions and Treatments | Pandemic Diseases | Information for Military Families

Diagnostic Testing for MERS-CoV by DoD Laboratories

Fact Sheet
6/16/2014

Diagnostic Testing for MERS-CoV by DoD Laboratories using the CDC Novel Coronavirus 2012 Real-Time RT-PCR Assay (MERS-CoV) For Emergency Use Only IAW Conditions of Authorization as specified in the FDA’s Emergency Use Authorization

Recommended Content:

Middle East Respiratory Syndrome Coronavirus | Pandemic Diseases
<< < 1 > >> 
Showing results 1 - 14 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.